Testing sputum rheology, sputum fourier transformed infrared spectroscopy and exhaled volatile organic compounds in diagnosing and monitoring chronic obstructive pulmonary disease (COPD)

Hywel Dda Health Board (UK)0 个研究点目标入组 300 人开始时间: 2010年6月25日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Patients (aged 40 - 90 years, either sex) with a diagnosis of COPD, according to Global initiative for chronic Obstructive Lung Disease (GOLD)
•2. Healthy controls with no symptoms of COPD and no evidence of airflow obstruction on spirometry

•1. Patients unable or unwilling to give informed consent
•2. Those with a current or previous diagnosis of cancer
•3. Those with known co-existent asthma, bronchiectasis or pulmonary fibrosis, severe heart failure (ejection fraction [EF] less than 35% on echocardiogram or chronic renal failure - estimated glomerular filtration rate [eGFR] less than 60/ml/min/1.73 m^2)
•4. Currently suffering an exacerbation (at enrolment)

发起方

Hywel Dda Health Board (UK)